QVT Associates GP LLC, 10% Owner at Urovant Sciences Ltd. (UROV), bought 43,216 shares at $8.39 ($326K) on 2019-05-20, disclosed to the SEC on 2019-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.79 | 5,408 | $37K | 11.3% |
| 2 | $6.79 | 5,408 | $37K | 11.3% |
| 3 | $7.36 | 6,200 | $46K | 14.0% |
| 4 | $7.36 | 6,200 | $46K | 14.0% |
| 5 | $7.98 | 8,285 | $66K | 20.3% |
| 6 | $7.98 | 8,285 |
| $66K |
| 20.3% |
| 7 | $8.39 | 1,715 | $14K | 4.4% |
| 8 | $8.39 | 1,715 | $14K | 4.4% |
| Total | $7.54 avg | 43,216 | $326K | 100% |
| Filing → |
| UROV | BUY | 2019-06-03 | $278K | — | Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $326K | — | Filing → |